[Clinical value of the measure of global fibrinolytic activity].
Guillaume
M
M
Laboratoires de Médecine expérimentale et de Biologie clinique, Service de Cardiologie, C.H.U. A. Vésale, Montigny-le-Tilleul, U.L.B.
Zouaoui Boudjeltia
K
K
Cauchie
P
P
Hénuzet
C
C
D001161:Arteriosclerosis / Q000097:blood* / Q000150:complications*; D001780:Blood Coagulation Tests / Q000379:methods* / Q000592:standards*; D002318:Cardiovascular Diseases / Q000209:etiology*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications*; D008297:Male; D017698:Postmenopause / Q000097:blood*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012712:Serum Globulins / Q000502:physiology*; D012907:Smoking / Q000009:adverse effects* / Q000097:blood*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000502:physiology*
D012712:Serum Globulins; D010959:Tissue Plasminogen Activator